The DOI matches its Crossref record; 91 of the 91 references it cites were found in a registry or an index.
Vancomycin-resistant enterococcal infections: epidemiology, clinical manifestations, and optimal management
Open accessAbstract
Since its discovery in England and France in 1986, vancomycin-resistant Enterococcus has increasingly become a major nosocomial pathogen worldwide. Enterococci are prolific colonizers, with tremendous genome plasticity and a propensity for persistence in hospital environments, allowing for increased transmission and the dissemination of resistance elements. Infections typically present in immunosuppressed patients who have received multiple courses of antibiotics in the past. Virulence is variable, and typical clinical manifestations include bacteremia, endocarditis, intra-abdominal and pelvic infections, urinary tract infections, skin and skin structure infections, and, rarely, central nervous system infections. As enterococci are common colonizers, careful consideration is needed before initiating targeted therapy, and source control is first priority. Current treatment options including linezolid, daptomycin, quinupristin/dalfopristin, and tigecycline have shown favorable activity against various vancomycin-resistant Enterococcus infections, but there is a lack of randomized controlled trials assessing their efficacy. Clearer distinctions in preferred therapies can be made based on adverse effects, drug interactions, and pharmacokinetic profiles. Although combination therapies and newer agents such as tedizolid, telavancin, dalbavancin, and oritavancin hold promise for the future treatment of vancomycin-resistant Enterococcus infections, further studies are needed to assess their possible clinical impact, especially in the treatment of serious infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hidron, A. I., Edwards, J. R., Patel, J., Horan, T. C., Sievert, D. M., Pollock, D. A., Fridkin, S. K., & National Healthcare Safety Network Team and Participating National Healthcare Safety Network Facilities (2008) · Infection Control & Hospital Epidemiology · doi:10.1086/591861 · Cited by 3,724
How long do nosocomial pathogens persist on inanimate surfaces? A systematic review
Kramer, A., Schwebke, I., & Kampf, G. (2006) · BMC Infectious Diseases · doi:10.1186/1471-2334-6-130 · Cited by 2,504
The life and times of the Enterococcus
Murray, B. E. (1990) · Clinical Microbiology Reviews · doi:10.1128/cmr.3.1.46 · Cited by 1,908
Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Bolger, A. F., Levison, M. E., Ferrieri, P., Gerber, M. A., Tani, L. Y., Gewitz, M. H., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.165564 · Cited by 1,707
Sievert, D. M., Ricks, P., Edwards, J. R., Schneider, A., Patel, J., Srinivasan, A., Kallen, A., Limbago, B., Fridkin, S., & National Healthcare Safety Network (NHSN) Team and Participating NHSN Facilities (2013) · Infection Control & Hospital Epidemiology · doi:10.1086/668770 · Cited by 1,582
Molecular mechanisms that confer antibacterial drug resistance
Walsh, C. (2000) · Nature · doi:10.1038/35021219 · Cited by 1,578
Plasmid-Mediated Resistance to Vancomycin and Teicoplanin in Enterococcus Faecium
Leclercq, R., Derlot, E., Duval, J., & Courvalin, P. (1988) · New England Journal of Medicine · doi:10.1056/nejm198807213190307 · Cited by 1,425
The ecology, epidemiology and virulence of Enterococcus
Fisher, K., & Phillips, C. (2009) · Microbiology · doi:10.1099/mic.0.026385-0 · Cited by 1,227
VANCOMYCIN-RESISTANT ENTEROCOCCI
Uttley, A. C., Collins, C. H., Naidoo, J., & George, R. C. (1988) · The Lancet · doi:10.1016/s0140-6736(88)91037-9 · Cited by 1,226
Vancomycin-Resistant Enterococci
Cetinkaya, Y., Falk, P., & Mayhall, C. G. (2000) · Clinical Microbiology Reviews · doi:10.1128/cmr.13.4.686 · Cited by 1,163
Infection with Vancomycin-Resistant Staphylococcus aureus Containing the vanA Resistance Gene
Chang, S., Sievert, D. M., Hageman, J. C., Boulton, M. L., Tenover, F. C., Downes, F. P., Shah, S., Rudrik, J. T., Pupp, G. R., Brown, W. J., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa025025 · Cited by 1,095
Vancomycin Resistance in Gram-Positive Cocci
Courvalin, P. (2006) · Clinical Infectious Diseases · doi:10.1086/491711 · Cited by 1,028
Vancomycin-Resistant Enterococcal Infections
Murray, B. E. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003093421007 · Cited by 890
Emergence and spread of vancomycin resistance among enterococci in Europe
Werner, G., Coque, T. M., Hammerum, A. M., Hope, R., Hryniewicz, W., Johnson, A., Klare, I., Kristinsson, K. G., Leclercq, R., Lester, C. H., et al. (2008) · Eurosurveillance · doi:10.2807/ese.13.47.19046-en · Cited by 539
Rosenthal, V. D., Bijie, H., Maki, D. G., Mehta, Y., Apisarnthanarak, A., Medeiros, E. A., Leblebicioglu, H., Fisher, D., Álvarez-Moreno, C., Khader, I. A., et al. (2012) · American Journal of Infection Control · doi:10.1016/j.ajic.2011.05.020 · Cited by 511
In vitro susceptibility studies of vancomycin-resistant Enterococcus faecalis
Sahm, D. F., Kissinger, J., Gilmore, M. S., Murray, P. R., Mulder, R., Solliday, J., & Clarke, B. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.9.1588 · Cited by 497
DiazGranados, C. A., Zimmer, S. M., Mitchel, K., & Jernigan, J. A. (2005) · Clinical Infectious Diseases · doi:10.1086/430909 · Cited by 459
Birmingham, M. C., Rayner, C. R., Meagher, A. K., Flavin, S. M., Batts, D. H., & Schentag, J. J. (2003) · Clinical Infectious Diseases · doi:10.1086/345744 · Cited by 428
Hill, E. E., Herijgers, P., Claus, P., Vanderschueren, S., Herregods, M.-C., & Peetermans, W. E. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl427 · Cited by 402
Vancomycin-resistant enterococci: why are they here, and where do they come from?
Bonten, M. J., Willems, R., & Weinstein, R. A. (2001) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(01)00145-1 · Cited by 400
Management of multidrug-resistant enterococcal infections
Arias, C. A., Contreras, G. A., & Murray, B. E. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03214.x · Cited by 388
New Lipoglycopeptides: A Comparative Review of Dalbavancin, Oritavancin and Telavancin
Zhanel, G. G., Calic, D., Schweizer, F., Zelenitsky, S., Adam, H., Lagacé-Wiens, P. R. S., Rubinstein, E., Gin, A. S., Hoban, D. J., & Karlowsky, J. A. (2010) · Drugs · doi:10.2165/11534440-000000000-00000 · Cited by 352
Emergence of vancomycin-resistant enterococci in New York City
Frieden, T. R., Munsiff, S. S., Williams, G., Faur, Y., Kreiswirth, B., Low, D. E., Willey, B. M., Warren, S., & Eisner, W. (1993) · The Lancet · doi:10.1016/0140-6736(93)91285-t · Cited by 338
Vergis, E. N., Hayden, M. K., Chow, J. W., Snydman, D. R., Zervos, M. J., Linden, P. K., Wagener, M. M., Schmitt, B., & Muder, R. R. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-7-200110020-00007 · Cited by 319
Fernández-Hidalgo, N., Almirante, B., Gavaldà, J., Gurgui, M., Peña, C., de Alarcón, A., Ruiz, J., Vilacosta, I., Montejo, M., Vallejo, N., et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit052 · Cited by 311
Rosenthal, V. D., Maki, D. G., Mehta, Y., Leblebicioglu, H., Memish, Z. A., Al-Mousa, H. H., Balkhy, H., Hu, B., Alvarez-Moreno, C., Medeiros, E. A., et al. (2014) · American Journal of Infection Control · doi:10.1016/j.ajic.2014.05.029 · Cited by 310
Studies on antibiotic synergism against enterococci
Moellering, R. C., & Weinberg, A. N. (1971) · Journal of Clinical Investigation · doi:10.1172/jci106758 · Cited by 302
Diversity among Multidrug-Resistant Enterococci
Murray, B. E. (1998) · Emerging Infectious Diseases · doi:10.3201/eid0401.980106 · Cited by 285
Fridkin, S. K., Edwards, J. R., Courval, J. M., Hill, H., Tenover, F. C., Lawton, R., Gaynes, R. P., McGowan, J. E., & for the Intensive Care Antimicrobial Resistance Epidemiology (ICARE) Project and the National Nosocomial Infections Surveillance (NNIS) System Hospitals (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-3-200108070-00009 · Cited by 279
Historical Yearly Usage of Vancomycin
Kirst, H. A., Thompson, D. G., & Nicas, T. I. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.5.1303 · Cited by 276
Singh, K. V., Weinstock, G. M., & Murray, B. E. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.6.1845-1850.2002 · Cited by 263
Tornieporth, N. G., Roberts, R. B., John, J., Hafner, A., & Riley, L. W. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/23.4.767 · Cited by 245
Van der Auwera, P., Pensart, N., Korten, V., Murray, B. E., & Leclercq, R. (1996) · Journal of Infectious Diseases · doi:10.1093/infdis/173.5.1129 · Cited by 237
Twenty-five years of shared life with vancomycin-resistant enterococci: is it time to divorce?
Cattoir, V., & Leclercq, R. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks469 · Cited by 234
The enterococcus: a classic example of the impact of antimicrobial resistance on therapeutic options
Moellering, R. C. (1991) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/28.1.1 · Cited by 225
Enterococcal Disease, Epidemiology, and Implications for Treatment
Higuita, N. I. A., & Huycke, M. M. (2014) · Europe PMC (PubMed Central) · Cited by 214
High-Level Resistance to Gentamicin in Clinical Isolates of Enterococci
Mederski-Samoraj, B. D., & Murray, B. E. (1983) · Journal of Infectious Diseases · doi:10.1093/infdis/147.4.751 · Cited by 213
vanM , a New Glycopeptide Resistance Gene Cluster Found in Enterococcus faecium
Xu, X., Lin, D., Yan, G., Ye, X., Wu, S., Guo, Y., Zhu, D., Hu, F., Zhang, Y., Wang, F., et al. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01710-09 · Cited by 213
Genetic Characterization of vanG , a Novel Vancomycin Resistance Locus of Enterococcus faecalis
McKessar, S. J., Berry, A. M., Bell, J. M., Turnidge, J. D., & Paton, J. C. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.11.3224-3228.2000 · Cited by 210
Vancomycin-resistant enterococci
Murray, B. E. (1997) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)80270-8 · Cited by 205
Vancomycin-Resistant Enterococci: Colonization, Infection, Detection, and Treatment
Zirakzadeh, A., & Patel, R. (2006) · Mayo Clinic Proceedings · doi:10.4065/81.4.529 · Cited by 192
The Pharmacokinetic and Pharmacodynamic Profile of Tigecycline
Meagher, A. K., Ambrose, P. G., Grasela, T. H., & Ellis‐Grosse, E. J. (2005) · Clinical Infectious Diseases · doi:10.1086/431674 · Cited by 188
Rosenthal, V. D., Bat-Erdene, I., Gupta, D., Belkebir, S., Rajhans, P., Zand, F., Myatra, S. N., Afeef, M., Tanzi, V. L., Muralidharan, S., et al. (2020) · American Journal of Infection Control · doi:10.1016/j.ajic.2019.08.023 · Cited by 188
High-level, plasmid-borne resistance to gentamicin in Streptococcus faecalis subsp. zymogenes
Horodniceanu, T., Bougueleret, L., El-Solh, N., Bieth, G., & Delbos, F. (1979) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.16.5.686 · Cited by 185
Mainardi, J.-L., Villet, R., Bugg, T. D., Mayer, C., & Arthur, M. (2008) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2007.00097.x · Cited by 184
Snyder, G. M., Thorn, K. A., Furuno, J. P., Perencevich, E. N., Roghmann, M.-C., Strauss, S. M., Netzer, G., & Harris, A. D. (2008) · Infection Control & Hospital Epidemiology · doi:10.1086/588701 · Cited by 183
Beta-lactamase-producing enterococci
Murray, B. E. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.11.2355 · Cited by 182
Diaz, L., Kiratisin, P., Mendes, R. E., Panesso, D., Singh, K. V., & Arias, C. A. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00419-12 · Cited by 181
Murray, K. P., Zhao, J. J., Davis, S. L., Kullar, R., Kaye, K. S., Lephart, P., & Rybak, M. J. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit112 · Cited by 178
Sakoulas, G., Bayer, A. S., Pogliano, J., Tsuji, B. T., Yang, S.-J., Mishra, N. N., Nizet, V., Yeaman, M. R., & Moise, P. A. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05551-11 · Cited by 176
d -Ala- d -Ser VanN-Type Transferable Vancomycin Resistance in Enterococcus faecium
Lebreton, F., Depardieu, F., Bourdon, N., Fines-Guyon, M., Berger, P., Camiade, S., Leclercq, R., Courvalin, P., & Cattoir, V. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00714-11 · Cited by 171
Balli, E. P., Venetis, C. A., & Miyakis, S. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01289-13 · Cited by 167
Enterococcal Bacteremia Clinical Implications and Determinants of Death
GARRISON, R. N., FRY, D. E., BERBERICH, S., & POLK, H. C. (1982) · Annals of Surgery · doi:10.1097/00000658-198207000-00010 · Cited by 166
Locke, J. B., Finn, J., Hilgers, M. T., Morales, G., Rahawi, S., Kedar, G. C., Picazo, J. J., Im, W., Shaw, K. J., & Stein, J. L. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00663-10 · Cited by 164
Synergistic effect of amoxicillin and cefotaxime against Enterococcus faecalis
Mainardi, J. L., Gutmann, L., Acar, J. F., & Goldstein, F. W. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.9.1984 · Cited by 164
Whole-Genome Analyses of Enterococcus faecium Isolates with Diverse Daptomycin MICs
Díaz, L., Tran, T. T., Munita, J. M., Miller, W. R., Rincón, S., Carvajal, L. P., Wollam, A., Reyes, J., Panesso, D., Rojas, N. L., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02686-14 · Cited by 153
Zhanel, G. G., Adam, H. J., Baxter, M. R., Fuller, J., Nichol, K. A., Denisuik, A. J., Lagacé-Wiens, P. R. S., Walkty, A. J., Karlowsky, J. A., Schweizer, F., et al. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt022 · Cited by 151
Guerrero, M. L. F., Goyenechea, A., Verdejo, C., Roblas, R. F., & Górgolas, M. (2007) · Medicine · doi:10.1097/md.0b013e31815d5386 · Cited by 141
Boyd, D. A., Willey, B. M., Fawcett, D., Gillani, N., & Mulvey, M. R. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01516-07 · Cited by 135
Management of Urinary Tract Infections From Multidrug-Resistant Organisms
Gupta, K., & Bhadelia, N. (2013) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2013.10.002 · Cited by 123
Robe-Rybkine, T., Mainardi, J., Sougakoff, W., Collatz, E., & Gutmann, L. (1998) · The Journal of Infectious Diseases · doi:10.1086/515605 · Cited by 122
Chuang, Y., Wang, J., Lin, H., & Chang, S. (2014) · BMC Infectious Diseases · doi:10.1186/s12879-014-0687-9 · Cited by 117
Enterococci and Vancomycin Resistance
French, G. L. (1998) · Clinical Infectious Diseases · doi:10.1086/514910 · Cited by 110
Papadimitriou‐Olivgeris, M., Δρούγκα, Ε., Fligou, F., Kolonitsiou, F., Liakopoulos, A., Dodou, V., Anastassiou, E. D., Petinaki, E. A., Marangos, M. N., Filos, K. S., et al. (2014) · Infection · doi:10.1007/s15010-014-0678-1 · Cited by 106
Lautenbach, E., Schuster, M. G., Bilker, W. B., & Brennan, P. J. (1998) · Clinical Infectious Diseases · doi:10.1086/515002 · Cited by 100
Defective killing of enterococci: a common property of antimicrobial agents acting on the cell wall
Krogstad, D. J., & Pargwette, A. R. (1980) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.17.6.965 · Cited by 100
Treatment of Vancomycin‐ResistantEnterococcus faeciumInfections with Quinupristin/Dalfopristin
Linden, P. K., Moellering, R. C., Wood, C. A., Rehm, S. J., Flaherty, J. P., Bompart, F., Talbot, G. H., & Synercid Emergency‐Use Study Group (2001) · Clinical Infectious Diseases · doi:10.1086/323899 · Cited by 95
Sakoulas, G., Rose, W., Nonejuie, P., Olson, J., Pogliano, J., Humphries, R., & Nizet, V. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02274-13 · Cited by 94
Multicenter Study of High-Dose Daptomycin for Treatment of Enterococcal Infections
Casapao, A. M., Kullar, R., Davis, S. L., Levine, D. P., Zhao, J. J., Potoski, B. A., Goff, D. A., Crank, C. W., Segreti, J., Sakoulas, G., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00526-13 · Cited by 88
Self-citationBrown, S. D., & Traczewski, M. M. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01569-09 · Cited by 84
Zacharioudakis, I. M., Zervou, F. N., Ziakas, P. D., Rice, L. B., & Mylonakis, E. E. (2014) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2014.05.016 · Cited by 77
Salgado, C. D. (2008) · American Journal of Infection Control · doi:10.1016/j.ajic.2008.10.010 · Cited by 75
Zhanel, G. G., Adam, H. J., Low, D. E., Blondeau, J. M., DeCorby, M. R., Karlowsky, J. A., Weshnoweski, B., Vashisht, R., Wierzbowski, A. K., & Hoban, D. J. (2011) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2010.10.025 · Cited by 75
Pfaller, M. A., Sader, H. S., & Jones, R. N. (2007) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2006.10.007 · Cited by 67
Werth, B. J., Steed, M. E., Ireland, C. E., Tran, T. T., Nonejuie, P., Murray, B. E., Rose, W. E., Sakoulas, G., Pogliano, J., Arias, C. A., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00098-14 · Cited by 66
AMINOGLYCOSIDE RESISTANT ENTEROCOCCAL ENDOCARDITIS
Eliopoulos, G. M. (1993) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(20)30509-2 · Cited by 63
Jenkins, I. (2007) · Journal of Hospital Medicine · doi:10.1002/jhm.236 · Cited by 61
Snyder, A. H., Werth, B. J., Barber, K. E., Sakoulas, G., & Rybak, M. J. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku113 · Cited by 60
Noskin, G. A., Siddiqui, F., Stosor, V., Kruzynski, J., & Peterson, L. R. (1999) · Clinical Infectious Diseases · doi:10.1086/517221 · Cited by 60
Entenza, J. M., Giddey, M., Vouillamoz, J., & Moreillon, P. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.12.022 · Cited by 59
Early Experience with Tedizolid: Clinical Efficacy, Pharmacodynamics, and Resistance
Rybak, J. M., Marx, K. R., & Martin, C. A. (2014) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1491 · Cited by 52
Tsigrelis, C., Singh, K. V., Coutinho, T. D., Murray, B. E., & Baddour, L. M. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.02188-06 · Cited by 48
Management of Multi-Drug Resistant Enterococcal Infections
Arias, C. A., Contreras, G. A., & Murray, B. E. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1198-743x.2010.03214.x · Cited by 46
Knoll, B. M., Hellmann, M., & Kotton, C. N. (2012) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365548.2012.717711 · Cited by 46
Werth, B. J., Barber, K. E., Tran, N. N., Nonejuie, P., Sakoulas, G., Pogliano, J., & Rybak, M. J. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku386 · Cited by 45
Mueller, S. W., Kiser, T. H., Anderson, T., & Neumann, R. T. (2012) · Annals of Pharmacotherapy · doi:10.1345/aph.1r412 · Cited by 40
Enterococcus Species, Streptococcus gallolyticus Group, and Leuconostoc Species
Arias, C. A., & Murray, B. E. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4801-3.00202-2 · Cited by 40
Single center experience of a vancomycin resistant enterococcal endocarditis cohort
Forrest, G. N., Arnold, R. S., Gammie, J. S., & Gilliam, B. L. (2011) · Journal of Infection · doi:10.1016/j.jinf.2011.08.014 · Cited by 34
Fisher, L. S., & North, D. S. (2009) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2008.11.003 · Cited by 18
Endocarditis Caused by Resistant Enterococcus: An Overview
Reyes, K., & Zervos, M. (2013) · Current Infectious Disease Reports · doi:10.1007/s11908-013-0348-y · Cited by 16
Hill, D. M., Wood, G. C., & Hickerson, W. L. (2014) · Annals of Pharmacotherapy · doi:10.1177/1060028014563066 · Cited by 11
Cited by
Antimicrobial Resistance in ESKAPE Pathogens
De Oliveira, D. M. P., Forde, B. M., Kidd, T. J., Harris, P. N. A., Schembri, M. A., Beatson, S. A., Paterson, D. L., & Walker, M. J. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00181-19 · Cited by 2,078
Antibiotic Resistance in Bacteria—A Review
Urban-Chmiel, R., Marek, A., Stępień-Pyśniak, D., Wieczorek, K., Dec, M., Nowaczek, A., & Osek, J. (2022) · Antibiotics · doi:10.3390/antibiotics11081079 · Cited by 580
The Surgical Infection Society Revised Guidelines on the Management of Intra-Abdominal Infection
Mazuski, J. E., Tessier, J. M., May, A. K., Sawyer, R. G., Nadler, E. P., Rosengart, M. R., Chang, P. K., O'Neill, P. J., Mollen, K. P., Huston, J. M., et al. (2017) · Surgical Infections · doi:10.1089/sur.2016.261 · Cited by 573
Biofilm-associated infection by enterococci
Ch’ng, J.-H., Chong, K. K. L., Lam, L. N., Wong, J. J., & Kline, K. A. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0107-z · Cited by 447
The Many Faces of Enterococcus spp.—Commensal, Probiotic and Opportunistic Pathogen
Krawczyk, B., Wityk, P., Gałęcka, M., & Michalik, M. (2021) · Microorganisms · doi:10.3390/microorganisms9091900 · Cited by 411
Metadata
- Authors
- Crank, C., & O'Driscoll, T.
- Venue
- Infection and Drug Resistance
- Publisher
- Informa UK Limited
- Published
- 2015-07
- Volume
- 8
- Pages
- 217
- ISSN
- 1178-6973 (ISSN-L)
- OpenAlex
- W2163750088
- Cited by
- 505
- References
- 91
- FWCI
- 14.02
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.